Although the correlation between PD-L1 expression and prognosis is not uniformly detected in various cancer types [42–45], several studies found that PD-L1 expression in tumors is a potential predictive biomarker for therapeutic blockade of the PD1/PD-L1 pathway [18, 19]. Here, CD274 is linked to cancer.